Clinical trial
Prometa Protocol for Alcohol Dependence
NCT00262639 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00262639 |
|---|---|
| Title | Prometa Protocol for Alcohol Dependence |
| Official title | A Double Blind Evaluation of Flumazenil and Gabapentin for the Treatment of Alcohol Withdrawal and Relapse Prevention |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alcohol Dependence |
| Intervention type | Drug |
| Interventions | Flumazenil and Gabapentin, Placebo |
| Enrollment | 60 |
| Start date | Dec 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Dec 7, 2005 |
| Last update posted | Feb 15, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: